John S. Driscoll

3.6k total citations
88 papers, 2.8k citations indexed

About

John S. Driscoll is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, John S. Driscoll has authored 88 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 41 papers in Organic Chemistry and 29 papers in Infectious Diseases. Recurrent topics in John S. Driscoll's work include HIV/AIDS drug development and treatment (29 papers), Biochemical and Molecular Research (20 papers) and HIV Research and Treatment (14 papers). John S. Driscoll is often cited by papers focused on HIV/AIDS drug development and treatment (29 papers), Biochemical and Molecular Research (20 papers) and HIV Research and Treatment (14 papers). John S. Driscoll collaborates with scholars based in United States, Malaysia and Japan. John S. Driscoll's co-authors include Víctor E. Márquez, Hiroaki Mitsuya, James A. Kelley, Abdul Hameed Khan, G. W. A. Milne, D.L. Williams, Marc C. Nicklaus, Shaomeng Wang, Samuel Broder and Wei Gao and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of The Electrochemical Society.

In The Last Decade

John S. Driscoll

88 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John S. Driscoll United States 29 1.3k 865 804 506 451 88 2.8k
John A. Secrist United States 38 3.4k 2.7× 1.7k 2.0× 1.4k 1.8× 780 1.5× 265 0.6× 169 5.5k
James A. Kelley United States 35 2.0k 1.6× 863 1.0× 763 0.9× 596 1.2× 358 0.8× 139 3.8k
Jerome P. Horwitz United States 27 1.0k 0.8× 1.0k 1.2× 454 0.6× 176 0.3× 249 0.6× 90 2.5k
Kent D. Stewart United States 34 1.3k 1.0× 967 1.1× 559 0.7× 518 1.0× 322 0.7× 91 3.1k
Franck Amblard United States 22 1.2k 0.9× 1.4k 1.6× 878 1.1× 524 1.0× 198 0.4× 87 3.0k
Joseph J. Barchi United States 36 3.0k 2.3× 1.6k 1.9× 477 0.6× 286 0.6× 267 0.6× 112 4.3k
Christian Périgaud France 28 1.7k 1.3× 952 1.1× 1.1k 1.3× 558 1.1× 350 0.8× 175 3.3k
T.K. Venkatachalam United States 30 513 0.4× 984 1.1× 651 0.8× 184 0.4× 450 1.0× 148 2.4k
David R. Langley United States 35 3.1k 2.5× 1.3k 1.5× 919 1.1× 905 1.8× 557 1.2× 82 5.6k
Krzysztof Appelt United States 30 2.2k 1.8× 733 0.8× 722 0.9× 138 0.3× 518 1.1× 85 3.9k

Countries citing papers authored by John S. Driscoll

Since Specialization
Citations

This map shows the geographic impact of John S. Driscoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Driscoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Driscoll more than expected).

Fields of papers citing papers by John S. Driscoll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Driscoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Driscoll. The network helps show where John S. Driscoll may publish in the future.

Co-authorship network of co-authors of John S. Driscoll

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Driscoll. A scholar is included among the top collaborators of John S. Driscoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Driscoll. John S. Driscoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ahluwalia, Gurpreet S., John S. Driscoll, Harry Ford, & David G. Johns. (1996). Comparison of the DNA Incorporation in Human MOLT-4 Cells of Two 2′-β-Fluoronucleosides, 2′-β-Fluoro-2′,3′-dideoxyadenosine and Fialuridine. Journal of Pharmaceutical Sciences. 85(4). 454–455. 3 indexed citations
3.
Ford, Harry, John S. Driscoll, Hao Zhang, et al.. (1995). Reversal by cytidine of cyclopentenyl cytosine-induced toxicity in mice without compromise of antitumor activity. Biochemical Pharmacology. 49(2). 173–180. 5 indexed citations
4.
5.
Nicklaus, Marc C., Shaomeng Wang, John S. Driscoll, & G. W. A. Milne. (1995). Conformational changes of small molecules binding to proteins. Bioorganic & Medicinal Chemistry. 3(4). 411–428. 185 indexed citations
6.
Milne, G. W. A., Marc C. Nicklaus, John S. Driscoll, Shaomeng Wang, & Daniel Zaharevitz. (1994). National Cancer Institute Drug Information System 3D Database. Journal of Chemical Information and Computer Sciences. 34(5). 1219–1224. 90 indexed citations
7.
Siddiqui, M. Arshad, John S. Driscoll, Víctor E. Márquez, et al.. (1992). Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines. Journal of Medicinal Chemistry. 35(12). 2195–2201. 20 indexed citations
8.
Shirasaka, Takuma, Eiji Kojima, Shizuko Aoki, et al.. (1991). Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides. Journal of Medicinal Chemistry. 34(5). 1606–1612. 29 indexed citations
9.
Tseng, Christopher K. H., Víctor E. Márquez, G. W. A. Milne, et al.. (1991). A ring-enlarged oxetanocin A analog as an inhibitor HIV infectivity. Journal of Medicinal Chemistry. 34(1). 343–349. 50 indexed citations
10.
Driscoll, John S., et al.. (1991). Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogs. Journal of Medicinal Chemistry. 34(11). 3280–3284. 62 indexed citations
11.
Barchi, Joseph J., Víctor E. Márquez, John S. Driscoll, et al.. (1991). Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs. Journal of Medicinal Chemistry. 34(5). 1647–1655. 59 indexed citations
12.
Márquez, Víctor E., Christopher K. H. Tseng, Hiroaki Mitsuya, et al.. (1990). Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV. Journal of Medicinal Chemistry. 33(3). 978–985. 183 indexed citations
13.
Márquez, Víctor E., et al.. (1988). Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties. Journal of Medicinal Chemistry. 31(9). 1687–1694. 69 indexed citations
14.
Dalal, Maha, Jacqueline Plowman, Theodore R. Breitman, et al.. (1986). Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic properties.. PubMed. 46(2). 831–8. 24 indexed citations
15.
Ai, Lin, James A. Kelley, Theodore R. Breitman, & John S. Driscoll. (1982). Agents with potential specificity against melanotic melanoma. Journal of Medicinal Chemistry. 25(5). 501–505. 12 indexed citations
16.
McCormack, John J., Víctor E. Márquez, Paul S. Liu, David T. Vistica, & John S. Driscoll. (1980). Inhibition of cytidine deaminase by 2-oxopyrimidine riboside and related compounds. Biochemical Pharmacology. 29(5). 830–832. 41 indexed citations
17.
Hirata, Tadashi, Geoffrey W. Peng, & John S. Driscoll. (1978). Potential CNS Antitumor Agents—Phenothiazines II: Fluphenazine Analogs. Journal of Pharmaceutical Sciences. 67(2). 157–162. 5 indexed citations
18.
Cooney, David A., John S. Driscoll, Harry A. Milman, Hiremagalur N. Jayaram, & Ruth D. Davis. (1976). Inhibitors of L-asparagine synthetase, in vitro.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60(10). 1493–557. 6 indexed citations
19.
Márquez, Víctor E., et al.. (1972). Intramolecular cyclizations leading to N-bridgehead bicyclics. 5,5-Diphenylhydantoin derivatives. The Journal of Organic Chemistry. 37(16). 2558–2561. 9 indexed citations
20.
Matthews, Clifford N., John S. Driscoll, & Gail H. Birum. (1966). Mesomeric phosphonium inner salts. Chemical Communications (London). 736–736. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John A. Secrist Breakdown of academic impact, for papers by James A. Kelley Breakdown of academic impact, for papers by Jerome P. Horwitz Breakdown of academic impact, for papers by Kent D. Stewart Breakdown of academic impact, for papers by Franck Amblard Breakdown of academic impact, for papers by Joseph J. Barchi Breakdown of academic impact, for papers by Christian Périgaud Breakdown of academic impact, for papers by T.K. Venkatachalam Breakdown of academic impact, for papers by David R. Langley Breakdown of academic impact, for papers by Krzysztof Appelt
Rankless by CCL
2026